Up to 8-year follow-up from RESONATE-2 : first-line ibrutinib treatment for patients with chronic lymphocytic leukemia

التفاصيل البيبلوغرافية
العنوان:	Up to 8-year follow-up from RESONATE-2 : first-line ibrutinib treatment for patients with chronic lymphocytic leukemia
المؤلفون:	Barr, Paul M., Owen, Carolyn, Robak, Tadeusz, Tedeschi, Alessandra, Bairey, Osnat, Burger, Jan A, Hillmen, Peter, Coutre, Steven E., Dearden, Claire, Grosicki, Sebastian, McCarthy, Helen, Li, Jian-Yong, Offner, Fritz, Moreno, Carol, Zhou, Ccathy, Hsu, Emily, Szoke, Anita, Kipps, Thomas J., Ghia, Paolo, Universitat AutÃ²noma de Barcelona
سنة النشر:	2022
المجموعة:	Universitat Autònoma de Barcelona: Dipòsit Digital de Documents de la UAB
الوصف:	Altres ajuts: AstraZeneca; TG Therapeutics; Acerta; Janssen.
نوع الوثيقة:	article in journal/newspaper
وصف الملف:	application/pdf
اللغة:	English
تدمد:	85131814 24739537
العلاقة:	Blood advances; Vol. 6 NÃºm. 11 (june 2022), p. 3440-3450; https://ddd.uab.cat/record/275200Test; urn:10.1182/bloodadvances.2021006434; urn:oai:ddd.uab.cat:275200; urn:scopus_id:85131814178; urn:articleid:24739537v6n11p3440; urn:oai:pubmedcentral.nih.gov:9198904; urn:pmid:35377947; urn:pmc-uid:9198904; urn:pmcid:PMC9198904
الإتاحة:	https://ddd.uab.cat/record/275200Test
حقوق:	open access ; Aquest document estÃ subjecte a una llicÃ¨ncia d'Ãºs Creative Commons. Es permet la reproducciÃ³ total o parcial, la distribuciÃ³, i la comunicaciÃ³ pÃºblica de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creaciÃ³ d'obres derivades. ; https://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام:	edsbas.46CE21B5
قاعدة البيانات:	BASE

View record in BASE

Full Text Finder

الوصف
تدمد:	85131814 24739537